Intrinsic Value of S&P & Nasdaq Contact Us

PureTech Health plc PRTC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$57.00
+212.3%

PureTech Health plc (PRTC) reported total assets of $553.24M and total liabilities of $184.22M for quarter ending 2025-06-30, resulting in total equity of $369.03M.

The company held $321.55M in cash and short-term investments. Total debt stood at $20.92M, with net debt of $-239.69M. The Debt-to-Equity (D/E) ratio was 0.06 (conservative).

Current ratio is 8.49, indicating strong short-term liquidity. Interest coverage is -50.2x (weak).

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (50/100) — Total assets $553.24M and equity $369.03M support the company's competitive scale
  • VALUE (91/100) — Debt-to-Equity 0.06 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 72/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
72/100
SG Score
View full scorecard →
VALUE
91/100
Price-to-Earnings & upside
→ Valuation
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
GROWTH
73/100
→ Income
INCOME
100/100
→ Income
PureTech Health plc Balance Sheet History
Metric Q2 FY2025 Q4 FY2024 Q2 FY2024 Q4 FY2023
Total Assets $553.24M$602.64M$579.95M$693.97M
Total Liabilities $184.22M$194.7M$273.74M$125.58M
Total Debt $20.92M$22.36M$144.73M$25.51M
Cash & Investments $321.55M$367.31M$500.42M$328.77M
Total Stockholders Equity $375.98M$414.71M$315.87M$464.07M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message